PROASSURANCE CORP 8-K

What Happened

• ProAssurance Corporation filed an 8-K dated June 26, 2026 reporting the completion of a previously announced merger transaction governed by the Agreement and Plan of Merger among ProAssurance, The Doctors Company and Jackson Acquisition Corporation (agreement dated March 19, 2025). The filing reflects a change in control and related corporate actions effective June 26, 2026, and includes a notice regarding delisting or failure to satisfy continued listing standards. The company also filed Certificate of Amendment No. 2 to its Certificate of Incorporation and a Fifth Restatement of its Bylaws, effective June 26, 2026.

Key Details

• Merger agreement referenced: Agreement and Plan of Merger dated March 19, 2025 (previously filed as an exhibit).
• Effective date of corporate changes and bylaws restatement: June 26, 2026.
• Items reported on the Form 8-K include: termination of a material definitive agreement, completion of an acquisition/disposition of assets, notice of delisting, material modification to security holder rights, changes in control, director/officer departures or elections, and amendments to articles/bylaws.
• Exhibits filed include Certificate of Amendment No. 2 to the Certificate of Incorporation and the Fifth Restatement of the Bylaws.

Why It Matters

• For investors, this filing signals a completed change in control and corporate reorganization that can materially affect share liquidity (delisting) and shareholder rights (charter/bylaw amendments).
• Delisting or removal from a national exchange typically makes trading shares harder and may reduce marketability and visibility of the stock.
• Charter and bylaw changes can alter governance, voting or transfer rights — shareholders should review the filed Certificate of Amendment and restated bylaws and monitor communications about next steps (e.g., tender offers, cash-out, or conversion mechanics).
• The filing contains forward-looking statements and references risks (regulatory approvals, litigation, integration effects, etc.) that may affect timing and outcomes; consult the full 8-K and related disclosures for details.